Co-Authors
This is a "connection" page, showing publications co-authored by Parth Modi and Ted Skolarus.
Connection Strength
2.967
-
Turnover Among Early-Career Advanced Practice Clinicians. JAMA Netw Open. 2025 May 01; 8(5):e258638.
Score: 0.249
-
Turnover Among Early Career Advanced Practice Providers in Urology. Urology. 2025 Feb 27.
Score: 0.246
-
Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019. Urol Oncol. 2025 May; 43(5):335.e9-335.e15.
Score: 0.240
-
Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2024 06; 188:80-86.
Score: 0.232
-
Industry Payments for Vibegron and Prescribing Patterns Among Urologic Clinicians. JAMA Health Forum. 2023 Dec 01; 4(12):e234020.
Score: 0.226
-
Using Implementation Science to Improve Patient Care. J Urol. 2023 10; 210(4):577-579.
Score: 0.221
-
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021. Urology. 2023 10; 180:121-129.
Score: 0.220
-
Outcomes of Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2023 08; 178:67-75.
Score: 0.217
-
Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Urology. 2021 09; 155:77-82.
Score: 0.186
-
Urologist practice structure and quality of prostate cancer care. Urol Pract. 2020 Sep; 7(5):419-424.
Score: 0.180
-
Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy. Urology. 2020 08; 142:99-105.
Score: 0.176
-
Practice-Level Adoption of Conservative Management for Prostate Cancer. J Oncol Pract. 2019 10; 15(10):e863-e869.
Score: 0.168
-
Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71.
Score: 0.164
-
Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371.
Score: 0.155
-
Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059.
Score: 0.045
-
Adoption of Abiraterone and Enzalutamide by Urologists. Urology. 2019 09; 131:176-183.
Score: 0.041